Emerge Diagnostics

About:

Emerge Diagnostics provides a tech-forward electrodiagnostic functional assessment solution.

Twitter/X: emergedx

Description:

Emerge Diagnostics is a California-based company focused on better management of musculoskeletal disorders with twin goals of better patient outcomes and reduced costs. The company's FDA-registered, the class-II diagnostic device is called an Electrodiagnostic Functional Assessment (EFA) that can age and evaluate muscle activity, distinguish between acute versus chronic injury, and objectively quantify effort, enabling physicians to get better diagnoses and save healthcare costs. The company was founded in 2012 and is headquartered in Carlsbad, California.

Total Funding Amount:

$9.34M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Carlsbad, California, United States

Founded Date:

2012-01-01

Founders:

Mary Rose Reaston, Phil Reaston

Number of Employees:

11-50

Last Funding Date:

2020-09-30

IPO Status:

Private

Industries: